Butterfly Network, Inc. (BFLY) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Butterfly Network, Inc.'s filing signal continuing positive.

Butterfly Network, Inc. is a pioneer in semiconductor-based point-of-care ultrasound (POCUS) technology, leveraging its proprietary Ultrasound-on-ChipTM platform to make ultrasound more accessible. The company's flagship solution consists of affordable, pocket-sized ultrasound devices that pair with cloud-connected software, enabling practical application of ultrasound information into clinical workflows. Butterfly's technology is designed for true mobility, powered by AI-driven tools and seamless hospital integration, supporting both large health systems and remote, resource-limited settings. The company also licenses its technology for co-development in non-competitive markets through its Butterfly EmbeddedTM program, targeting areas like brain computer interfaces and surgical robotics. Butterfly generated $97.6 million in revenue in 2025, selling its products in over 30 countries.

Revenue is generated from the sale of medical devices, accessories, and semiconductor chips, as well as software subscriptions and other related services. The company also generates revenue through out-licensing arrangements of its intellectual property.